Measurements of urinary calcium excretion are of the results in anyone patient over a period of time when alterations in plasma protein concentration may occur. It does not seem, at present, to be of value to attach much emphasis to the stability or otherwise of the plasma calcium concentration in patients with hypercalcaemia. Some workers have claimed 'fluctuations' as a diagnostic feature of the hypercalcaemia of primary hyperparathyroidism, when compared with hypercalcaemia due to other causes (McGeown, 1963) while others have been impressed by its 'remarkable stability' (Keating, 1961) .
Calcium exists in blood plasma in a non-diffusible and a diffusible portion, depending on its ability to pass across a semipermeable membrane. The nondiffusible or protein-bound fraction constitutes approximately 40 %of the total and is mainly bound to albumin (approximately 0.7 mg/g of albumin), with only a small portion attached to the globulins. Diffusible plasma calcium is sub-divided further into ionised and complexed fractions, the former being the major part. The complexed fraction consists of calcium loosely complexed with, mainly, bicarbonate, citrate and phosphate. The physiologically active fraction, to which the parathyroid glands respond, is the ionised portion (Copp, 1969) and alterations in the state of calcium fractions in the plasma have, in the past, been considered to be of value in the differential diagnosis of hypercalcaemia (Fanconi and Rose, 1958) . In our own studies where we have measured the total and ultrafiltrable, and the total and ionised plasma calcium concentrations, we have shown significant correlation between both of these variables with the total calcium concentration over a wide range of the latter (Wills and Lewin, 1970) . Our studies include normal subjects, patients with hypercalcaemia due to metastatic carcinoma as well as primary hyperparathyroidism and patients with hypocalcaemia due to various causes including chronic renal failure. Our results suggest that the determination of ionised plasma calcium concentration, a time consuming procedure, is of little value in the differential diagnosis of hypercalcaemia of primary hyperparathyroidism from that due to other causes. -specific, or 
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Plasma calcium
The tests which are used in the differential diagnosis of hypercalcaemia are based on the two principal physiological functions of parathyroid hormone in the regulation of calcium homeostasis. In bone parathyroid hormone stimulates directly the rate of osteoclastic resorption, and in the renal tubules it affects the rate of phosphate reabsorption. The diagnostic tests available can be classed as either specific, or direct, and non-specific, or indirect, depending on their relationship to these actions of parathyroid hormone (Table I ).
In the collection of blood for calcium determination it has been well established that venous stasis can cause a significant increase in plasma calcium concentration. Ideally the patient should be fasting but in our experience this is not essential as increments in plasma calcium concentration have been found to be, at the most, 0.5--0.8 mgfl00 ml after normal meals or even large oral calcium loads (Wills, unpublished data) . The use of a protein correction factor as proposed by Dent (1962) is of value in the interpretation ofplasma calcium values if 'artificially' high values due to venous stasis are to be excluded. The use of such a factor is also of value in comparing Urinary calcium themselves little help in the differentiation of the hypercalcaemia of primary hyperparathyroidism from that due to other causes. Hypercalciuria occurs in 20-30% of patients with primary hyperparathyroidism (Pyrah, Hodgkinson, and Anderson, 1966; Strott and Nugent, 1968 ) and since urinary calcium excretion represents the end result of the processes of filtration and tubular reabsorption of diffusible plasma calcium, any patient with hypercalcaemia will have an increased filtered calcium load which will be reflected as an increased urinary calcium excretion.
Serum phosphorus
Hypophosphataemia due to the blocking effect of parathyroid hormone on the renal tubular reabsorption of phosphate should be a distinguishing feature in patients with hypercalcaemia due to primary hyperparathyroidism, compared with those due to other causes. Consistently low values for serum phosphorus concentration are however, the exception rather than the rule, even in the presence of normal renal function. We have, in the past, shown a marked overlap between plasma phosphorus concentration in patients with primary hyperparathyroidism when compared with patients with hypercalcaemia due to various other causes (Wills and McGowan, 1964a) . A consistently low plasma phosphorus concentration is suggestive of primary hyperparathyroidism, but the diagnosis is not excluded in the presence of a normal or high concentration.
Phosphate excretion tests
These tests are all based on the action of parathyroid hormone at the renal tubular level in blocking net phosphorus reabsorption. They were devised in an attempt to improve both the diagnostic accuracy in patients with borderline primary hyperparathyroidism, and to differentiate patients with hypercalcaemia due to primary hyperparathyroidism from patients with hypercalcaemia due to other causes. The tests (Table 2) , have been Table 2 . Phosphate excretion tests.
Simple procedures
Phosphate/creatinine clearance ratio (Cp/Ccr). Tubular reabsorptionof phosphate (TRP). Phosphateexcretion index (PEl) Phosphateclearance (CPQ4).
Complex procedures
Theoretical renal phosphate threshold (RPThr). Maximum tubular reabsorptionof phosphate(TmP). 137 expressed in a variety of clearance equations and can be divided into simple and more complex procedures (Nordin and Smith, 1965) . If the patients are on controlled phosphate intake, have normal or nearly normal renal function, and do not have glycosuria, these tests maybe useful in the delineation of borderline cases of primary hyperparathyroidism. Abnormalities in the renal handling of phosphorus do however, occur in a variety of other conditions which may themselves cause hypercalcaemia, and these include sarcoidosis and myeloma, Because of the technical difficulties in performing these tests, the more complex of which require constant infusion and rigidly controlled dietary phosphorus intake, I personally feel that they are of very limited diagnostic value.
Calcium tolerance test
The secretion of parathyroid hormone is controlled by the circulating concentration of ionised calcium. The calcium tolerance tests were designed to suppress the endogenous production of parathyroid hormone in normal glands, which would not occur if the glands were autonomous so differentiating hypercalcaemia of parathyroid origin from that due to other causes. The changes measured following calcium infusions are usually based on alterations in urinary phosphorus excretion as an index of parathyroid suppression (Pronove and Bartter, 1961) . The value of these tests in the differential diagnosis of hypercalcaemia has however, been questioned since hyperparathyroid responses have been observed in other hypercalcaemics and negative results have been obtained in patients with proven primary hyperparathyroidism (Strott and Nugent, 1968) .
Parathyroid hormone assay
In recent years with the development of radioimmuno-assay techniques for parathyroid hormone it has become possible to establish a diagnosis in patients with primary hyperparathyroidism where there is an increased concentration of hormone in the peripheral blood. In the absence of any disorder of parathyroid hormone secretion it would be anticipated that circulating parathyroid hormone concentration would be depressed in patients with hypercalcaemia due to other causes. There are however, some conflicting observations that are as yet unresolved. Some workers have reported an overlap between the concentration of hormone circulating in normal subjects and that in patients with primary hyperparathyroidism , while others have claimed that a clear distinction can be made between normal subjects and patients with primary hyperparathyroidism (Reiss and Canterbury, 1969) . Some of these conflicting reports may be due to either variations in methodology or perhaps are related to the relatively short half life of parathyroid hormone (Buckle, 1969) . As well as estimations of parathyroid hormone concentration in peripheral blood, hormone concentrations have been determined in blood obtained at neck vein catheterisation in attempts to localise an adenoma prior to surgical exploration (Reitz et al., 1969) .At the present time radioimmuno-assay remains a research procedure and although it offers great hope for the future it is not yet widely available.
NON-SPECIFIC TESTS
Alkaline phosphatase
In the absence of liver disease the plasma alkaline phosphatase concentration is a direct reflection of osteoblastic activity and therefore of bone remodelling. The determination of plasma alkaline phosphatase activity is therefore of itself of little value in the differential diagnosis of hypercalcaemia. In their study of 70 patients with primary hyperparathyroidism Dent and Harper (1962) divided the patients into two groups on the basis of plasma alkaline phosphatase activity. Those with raised alkaline phosphatase had specific radiological signs of hyperparathyroidism.
Urinary hydroxyproline
Hydroxyproline is a non-essential amino acid that occurs almost exclusively in collagen where it accounts for some 14% of the total amino acids. In patients with primary hyperparathyroidism or following the administration of parathyroid extract to normal human subjects the urinary excretion of hydroxyproline is increased. This is attributed to accelerated bone turnover and collagen degradation. In such patients the increase in urinary hydroxyproline excretion appears to be a more sensitive index of bone involvement than the plasma alkaline phosphatase concentration. As urinary hydroxyproline excretion is directly correlated with the rate of bone destruction its determination is of no value in the differential diagnosis of patients with hypercalcaemia, where bone destruction due to a variety of causes may account for the hypercalcaemia.
Cortisone suppression test
This test arose out of work that was being done some years ago on sarcoidosis, partly by clinicians who were using cortisone therapy, and partly by others in a detailed study of the calcium disorder associated with sarcoidosis. The test as originally described (Dent. 1956 ) involved the oral administration of a standard lQ-day load of cortisone that was given orally in a dose of 50 mg three times a day, and recently hydrocortisone has been used instead (Dent and Watson, 1968) . Early observations with this test showed that unlike hypercalcaemia of sarcoidosis, myelomatosis, thyrotoxicosis, Vitamin D intoxication and malignant disease, the hypercalcaemia associated with primary hyperparathyroidism was unresponsive to the administration of cortisone. Since the original description of this test there have been reports of patients with proven primary hyperparathyroidism who have shown suppression of their hypercalcaemia and there also have been reports of patients with hypercalcaemia due to various other causes who have failed to show suppression. In many of these conflicting reports the workers have not used the method as originally described, and have used various other steroid substitutes. The mechanism by which cortisone or hydrocortisone lowers the plasma calcium concentration in patients with hypercalcaemia due to causes other than primary hyperparathyroidism is unexplained. In our experience the use of cortisone, or hydrocortisone, is valuable in the differential diagnosis of patients with hypercalcaemia with particular reference to primary hyperparathyroidism, although it has not provided a clear delineation between hypercalcaemic patients. It is important to stress that it is unwise to suddenly stop the administration of the steroid at the end of the test period, owing to potential adrenocortical suppression. The steroid should be tailed off slowly over at least a week; and parathyroid gland exploration should not be undertaken immediately unless steroid cover is given.
Acid-base changes
It was reported some years ago that the plasma chloride concentration was significantly higher in patients with primary hyperparathyroidism than in patients with hypercalcaemia due to various other causes (Wills and McGowan, 1964a) . This has since been confirmed by other workers (Heinemann, 1965; Pyrah, Hodgkinson, and Anderson, 1966; Lafferty, 1966) . These changes in chloride concentration represent a fundamental difference between patients with primary hyperparathyroidism who tend towards metabolic acidosis. and those with hypercalcaemia due to various other causes including malignant disease, who have a metabolic alkalosis (Wills and McGowan, 1964b; Wills, unpublished data) . The exact mechanism producing these acid-base changes remains to be clarified. It was postulated originally that these changes represented an alteration in acidbase homeostasis at the renal tubular level associated with the liberation of excessive quantities of base phosphate from bone in the non-parathyroid hypercalcaemic patients: the effects of phosphate liberation were counteracted in the patients with primary hyperparathyroidism where the renal tubular effects of parathyroid hormone are such as to cause a metabolic acidosis (Wills, 1964) . It is of considerable interest that in patients with hypocalcaemia due to hypoparathyroidism it has recently been reported that there is a metabolic alkalosis (Barzel, 1969) which was attributed to the absence of parathyroid hormone. Barzel postulated that in the absence of parathyroid hormone there might be a failure of tubular reabsorption of hydrogen ion and/or a failure of citric acid formation. These two factors, either individually or together, resulted in a reduction of extra-cellular hydrogen ion concentration. This hypothesis could also account for the metabolic alkalosis found in the patients with hypercalcaemia due to causes other than hyperparathyroidism where there would be presumably suppression of endogenous parathyroid hormone secretion. In our own experience we have found that alterations in plasma chloride concentration and acid-base status are of considerable value in the differential diagnosis of hypercalcaemia due to primary hyperparathyroidism from that due to all other causes.
Sodium chloride infusion
It has been reported that the infusion of hypertonic sodium chloride produced a marked increase in the urinary calcium excretion in patients with primary hyperparathyroidism but not in a control group (Axelrod, 1966) . In our own studies of the interrelationships of the urinary excretion of calcium and sodium we have been unable to observe any relationship between these two ions during various regimens affecting the excretion of either (Wills, Gill, and Bartter, 1969) . Our results suggest that these regimens produce their effects through alteration of tubular function rather than through an effect of one ion, sodium or calcium, on tubular reabsorption. There seems therefore to be little value, if any, in tests based on sodium and chloride induced hypercalcuria in the differential diagnosis of hypercalcaemia.
Tubular reabsorption ofglucose
It has been reported that in patients with primary hyperparathyroidism the maximal reabsorptive capacity for glucose and the reabsorptive capacity in relation to the glomerular filtration rate was elevated 139 and following parathyroidectomy there was a pronounced decrease (Halver, 1966) . It was suggested that this type of technique was of value in differentiating hypercalcaemia due to parathyroid disease from that due to other causes. The studies using this technique are at the present moment limited (Heath and Knapp, 1969) , and as the test is time consuming with overlap occurring between patient groups its place in differential diagnosis is limited (Heath, personal communication) .
Venous compression test
It has been known for years that venous occlusion of the arm causes haemoconcentration by ultrafiltration in vivo and a technique for the estimation of ionised calcium concentration has been based on this observation (van Leeuwen, Thomasse, and Kapteyn, 1961) . Recently it has been reported that venous compression of the arm (100 mmHg) with rhythmical fist-clenching for 15 min. in hyperparathyroid patients caused a substantial rise in plasma calcium concentration in that arm, when compared with normal subjects (Krull, Muller, Leijnse, and Gerbrandy, 1969) . It was proposed that this effect was associated with local acidosis augmenting the skeletal release of calcium in the hyperparathyroid patients, this explanation hardly seems tenable as the authors state that there was no rise in plasma phosphorus concentration. The use of such a test in the differential diagnosis of hypercalcaemia would, at present, appear to be limited.
CONCLUSIONS
In taking 'A new look at the biochemical investigation of patients' with special reference to the differential diagnosis of hypercalcaemia due to primary hyperparathyroidism from that due to various other causes, the tests that should be employed are:-Firstly the accurate repeated determination of total plasma calcium concentration with correction for total protein concentration to obtain comparative results over long periods of time, the samples being collected with meticulous technique. Hypercalcaemia is defined in accordance with Keating (1961) who regarded a plasma calcium concentration as abnormal if it exceeded the 99 percentile limits of normal (Mean + 3 S.D.).
Secondly the cortisone suppression or hydrocortisone suppression test, to differentiate between difficult cases in whom there is no radiological or other definitive evidence that allows a differentiation to be undertaken. The test being performed as detailed by its original proponents.
Thirdly the determination of plasma electrolytes, in particular the chloride concentration, together with an assessment of acid-base status by separate independent measurements of pH, Peol and bicarbonate concentrations.
Finally, for the future, the determination of circulating parathyroid hormone concentration may become the definitive test in the differential diagnosis of hypercalcaemia, which at present often still requires the surgical exploration of the neck, identification of and biopsy of all four parathyroid glands.
